Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management

Comprehensive molecular landscaping studies reveal a potentially brighter future for pancreatic ductal adenocarcinoma (PDAC) patients. Blood-borne biomarkers obtained from minimally invasive “liquid biopsies” are now being trialled for early disease detection and to track responses to therapy. Integ...

Full description

Bibliographic Details
Published in:Frontiers in Cell and Developmental Biology
Main Authors: Daniel Schreyer, John P. Neoptolemos, Simon T. Barry, Peter Bailey
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.795735/full